Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA)

Historical Holders from Q3 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.00001 par value
Symbol
TSHA on Nasdaq
Shares outstanding
274,772,727
Price per share
$5.50
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
264,427,699
Holdings value
$864,676,435
% of all portfolios
0.01%
Share change
+6,900,092
Value change
+$29,348,999
Average buys %
+0%
Average sells %
-0%
Number of holders
150
Price from insider filings
$4.51
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $90,456,313 +$7,574,932 27,662,481 +9.1% RA Capital Management, L.P. 30 Sep 2025
Manning Paul B 9.8% $76,803,333 25,601,111 Paul B Manning 30 May 2025
RTW INVESTMENTS, LP 9.9% -0.9% $75,549,861 +$13,529,940 25,183,287 +22% RTW Investments, LP 30 Jun 2025
MORGAN STANLEY 6.7% -21% $39,112,054 -$1,787,838 16,858,644 -4.4% Morgan Stanley 30 Jun 2025
FMR LLC 6.2% -22% $36,256,547 -$1,711,793 15,627,822 -4.5% FMR LLC 30 Jun 2025
BlackRock, Inc. 5.2% $30,515,716 13,153,326 BlackRock, Inc. 30 Jun 2025
GOLDMAN SACHS GROUP INC 5.1% $29,577,606 12,748,968 THE GOLDMAN SACHS GROUP, INC. 26 Jun 2025
Octagon Capital Advisors LP 3.3% -36% $29,650,725 -$4,520,775 9,067,500 -13% Octagon Capital Advisors LP 30 Sep 2025
As of 30 Sep 2025, Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA) has 150 institutional shareholders filing 13F forms. They hold 264,427,699 shares of 274,772,727 outstanding shares (96%) .

Top 25 institutional shareholders own 85% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
RTW INVESTMENTS, LP 8.9% 24,354,291 -2.7% 0.98% $79,638,532
RA CAPITAL MANAGEMENT, L.P. 8.6% 23,555,648 0% 0.95% $77,026,969
Avoro Capital Advisors LLC 7.9% 21,700,000 0% 0.92% $70,959,000
MORGAN STANLEY 7% 19,307,603 +14% 0% $63,135,862
BlackRock, Inc. 6% 16,364,861 +23% 0% $53,513,096
FMR LLC 5.3% 14,593,412 -6.6% 0% $47,720,458
GOLDMAN SACHS GROUP INC 4.9% 13,383,708 +6.3% 0.01% $43,764,725
VANGUARD GROUP INC 4.7% 12,849,613 +18% 0% $42,018,234
Siren, L.L.C. 4% 11,014,737 0% 1.4% $36,018,190
Octagon Capital Advisors LP 3.3% 9,067,500 -28% 4.6% $29,650,725
Point72 Asset Management, L.P. 2.7% 7,331,470 +0.19% 0.05% $23,973,907
STATE STREET CORP 2.6% 7,236,465 +41% 0% $23,663,241
Vestal Point Capital, LP 2% 5,500,000 +83% 0.82% $17,985,000
DEERFIELD MANAGEMENT COMPANY, L.P. 2% 5,386,000 0% 0.27% $17,612,220
Polar Capital Holdings Plc 1.9% 5,293,879 +5.9% 0.08% $17,310,984
GEODE CAPITAL MANAGEMENT, LLC 1.9% 5,174,516 +36% 0% $16,924,446
BARCLAYS PLC 1.9% 5,148,112 +1043% 0.01% $16,834,325
MILLENNIUM MANAGEMENT LLC 1.5% 4,026,122 +37% 0.01% $13,165,419
BAKER BROS. ADVISORS LP 1.5% 4,004,756 0% 0.09% $13,095,552
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1.3% 3,700,000 -9.6% 39% $12,099,000
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.2% 3,328,000 -31% 0.02% $10,882,560
Affinity Asset Advisors, LLC 1.1% 3,000,000 +1400% 0.91% $9,810,000
ADAR1 Capital Management, LLC 1% 2,835,680 -5.8% 0.92% $9,272,674
D. E. Shaw & Co., Inc. 0.98% 2,706,434 +574% 0.01% $8,850,039
Jefferies Financial Group Inc. 0.78% 2,156,642 -79% 0.06% $7,052,219

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 781,780 $4,299,683 +$4,118,331 $5.50 3
2025 Q3 264,427,699 $864,676,435 +$29,348,999 $3.27 150
2025 Q2 257,684,976 $595,324,582 +$211,768,583 $2.31 147
2025 Q1 166,761,354 $231,855,054 -$5,171,832 $1.39 124
2024 Q4 167,089,013 $289,098,804 +$18,983,328 $1.73 125
2024 Q3 156,893,147 $315,364,730 -$17,625,139 $2.01 114
2024 Q2 158,086,076 $354,139,421 +$33,922,199 $2.24 102
2024 Q1 140,089,173 $401,959,511 +$19,199,179 $2.87 105
2023 Q4 130,129,882 $230,288,972 -$12,408,685 $1.77 85
2023 Q3 129,862,060 $410,364,849 +$376,273,584 $3.16 61
2023 Q2 13,698,356 $9,051,371 -$2,014,690 $0.6610 37
2023 Q1 16,687,605 $13,286,354 -$3,025,812 $0.7976 42
2022 Q4 19,375,255 $43,785,515 +$11,947,434 $2.26 51
2022 Q3 12,891,725 $25,021,000 -$1,790,730 $1.93 47
2022 Q2 14,629,559 $54,431,000 -$11,130,128 $3.72 53
2022 Q1 16,839,266 $109,746,239 -$16,441,631 $6.52 68
2021 Q4 18,273,544 $212,886,592 -$15,463,883 $11.65 60
2021 Q3 19,436,846 $361,910,267 +$2,739,579 $18.62 48
2021 Q2 18,320,631 $388,396,891 +$15,024,022 $21.20 48
2021 Q1 17,661,042 $358,518,075 -$11,638,282 $20.30 46
2020 Q4 16,933,973 $446,962,635 +$34,062,857 $26.54 49
2020 Q3 16,580,732 $366,712,000 +$366,712,047 $22.40 46